Indeed, irbesartan was reported to relieve steatosis in db/db mice by activating the AMPK/Akt/mTOR pathway and inducing autophagy (Zhong et al., 2017), and the results was also a proof that irbesartan regulated autophagy in ameliorating lipid accumulation. Here, AKT1 is linked to steatosis.